{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T10:52:05Z","timestamp":1763808725291},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,12,28]],"date-time":"2007-12-28T00:00:00Z","timestamp":1198800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s11239-007-0183-9","type":"journal-article","created":{"date-parts":[[2007,12,27]],"date-time":"2007-12-27T03:48:17Z","timestamp":1198727297000},"page":"146-153","source":"Crossref","is-referenced-by-count":3,"title":["Eptifibatide does not suppress the increase of inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome"],"prefix":"10.1007","volume":"27","author":[{"given":"Alexey A.","family":"Mazaev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaroslav A.","family":"Naimushin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery P.","family":"Masenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail Y.","family":"Ruda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey V.","family":"Mazurov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,28]]},"reference":[{"key":"183_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"40","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2014an inflammatory disease. N Engl J Med 40:115\u2013125","journal-title":"N Engl J Med"},{"key":"183_CR2","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1016\/S0735-1097(02)02833-4","volume":"41","author":"R Corti","year":"2003","unstructured":"Corti R, Fuster V, Badimon JJ (2003) Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol 41:7S\u201314S","journal-title":"J Am Coll Cardiol"},{"key":"183_CR3","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0735-1097(02)02953-4","volume":"41","author":"GR Blake","year":"2003","unstructured":"Blake GR, Ridker PM (2003) C-reactive protein and other inflammatory risk factors in acute coronary syndromes. J Am Coll Cardiol 41:37S\u201342S","journal-title":"J Am Coll Cardiol"},{"key":"183_CR4","first-page":"e560","volume":"111","author":"LM Biasucci","year":"2004","unstructured":"Biasucci LM (2004) CDC\/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular disease: a background paper. Circulation 111:e560\u2013567","journal-title":"Circulation"},{"key":"183_CR5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00062752-200309000-00006","volume":"10","author":"KS Prasad","year":"2003","unstructured":"Prasad KS, Andre P, Phillips DR (2003) The platelet CD40L\/GP IIb-IIIa axis in atherothrombotic disease. Curr Opin Hematol 10:356\u2013361","journal-title":"Curr Opin Hematol"},{"key":"183_CR6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/359848a0","volume":"359","author":"T Palabrica","year":"1992","unstructured":"Palabrica T, Lobb R, Furie BC, Aranovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B (1992) Leukocyte accumulation promoting fibrin deposition is mediated in\u00a0vivo by P-selectin on adherent platelets. Nature 359:848\u2013851","journal-title":"Nature"},{"key":"183_CR7","first-page":"35","volume":"10","author":"AR Gear","year":"2003","unstructured":"Gear AR, Camerini D (2003) Platelet chemokines and chemokine receptors: linking hemostasis, inflammation and host defense. Microcurculation 10:35\u201350","journal-title":"Microcurculation"},{"key":"183_CR8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2004-06-2475","volume":"105","author":"P Hundelshausen Von","year":"2005","unstructured":"Von Hundelshausen P, Koenen RR, Sack M, Mause SF, Adriaens W, Proudfoot AL, Hackeng TM, Weber C (2005) Heteropfilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105:924\u2013930","journal-title":"Blood"},{"key":"183_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrd985","volume":"2","author":"DL Bhatt","year":"2003","unstructured":"Bhatt DL, Topol EJ (2003) Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov 2:15\u201328","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl. E","key":"183_CR10","first-page":"E11","volume":"1","author":"N Chronos","year":"1999","unstructured":"Chronos N, Marciniak SJ, Nakada MT (1999) Binding specificity and associated effects of platelet GP IIb-IIIa inhibitors. Eur Heart J Suppl 1(Suppl. E):E11\u201317","journal-title":"Eur Heart J Suppl"},{"key":"183_CR11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1022605613859","volume":"68","author":"YaA Naimushin","year":"2003","unstructured":"Naimushin YaA, Mazurov AV (2003) Role of glycoprotein IIb-IIIa (\u03b1IIb\u03b23-integrin) in stimulation of secretion from platelet granules. Biochemictry (Moscow) 68:209\u2013216","journal-title":"Biochemictry (Moscow)"},{"key":"183_CR12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.CIR.0000053559.46158.AD","volume":"107","author":"L Nannizzi-Alaimo","year":"2003","unstructured":"Nannizzi-Alaimo L, Alves VL, Phillips DR (2003) Inhibitory effects of glycoprotein IIb-IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. Circulation 107:1123\u20131128","journal-title":"Circulation"},{"key":"183_CR13","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2003.12.055","volume":"43","author":"MI Furman","year":"2004","unstructured":"Furman MI, Krueger LA, Linden MD, Barnard MR, Frelinder AL, Michelson AD (2004) Release of soluble CD40L from platelets is regulated by glycoprotein IIb\/IIIa and actin polymerization. J Am Coll Cardiol 43:2326\u20132328","journal-title":"J Am Coll Cardiol"},{"key":"183_CR14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2005.01124.x","volume":"3","author":"MI Furman","year":"2005","unstructured":"Furman MI, Krueger LA, Linden MD, Fox ML, Ball SP, Barnard MR, Frelinder AL III, Michelson AD (2005) GP IIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention. J Thromb Haemost 3:312\u2013320","journal-title":"J Thromb Haemost"},{"key":"183_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ccd.10763","volume":"61","author":"FG Welt","year":"2004","unstructured":"Welt FG, Rogers SD, Zhang X, Ehlers R, Chen Z, Nannizzi-Alaimo L, Phillips DR, Simon DI (2004) GP IIb-IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention. Catheter Cardiovasc Interv 61:185\u2013189","journal-title":"Catheter Cardiovasc Interv"},{"key":"183_CR16","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.STR.0000094425.06242.64","volume":"34","author":"CW Kopp","year":"2003","unstructured":"Kopp CW, Steiner S, Nasel C, Seidinger D, Mlekusch I, Lang W, Bartok A, Armadi R, Minar E (2003) Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting. Stroke 34:2560\u20132567","journal-title":"Stroke"},{"key":"183_CR17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.CIR.104.2.163","volume":"104","author":"AM Lincoff","year":"2001","unstructured":"Lincoff AM, Kereiakis DJ, Marcelli MA, Deckelbaum LI, Barnathan ES, Patel KK, Frederick B, Nakada MT, Topol EJ (2001) Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 104:163\u2013167","journal-title":"Circulation"},{"key":"183_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ahj.2003.09.014","volume":"147","author":"SK James","year":"2004","unstructured":"James SK, Siegbahn A, Armstrong P, Barnathan E, Califf R, Simoons ML, Wallentin L (2004) Activation of the inflammation, coagulation and fibrinolysis systems without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with deltaparin: a GUSTO IV substudy. Am Heart J 147:267\u2013274","journal-title":"Am Heart J"},{"key":"183_CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1067\/mhj.2003.65","volume":"145","author":"AW Bonz","year":"2003","unstructured":"Bonz AW, Lengenfelder B, Jakobs M, Strotmann J, Held S, Ertl G, Voelker W (2003) Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb\/IIIa receptor antagonism. Am Heart J 145:693\u2013699","journal-title":"Am Heart J"},{"key":"183_CR20","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1016\/S0002-8703(03)00447-2","volume":"147","author":"E Ercan","year":"2004","unstructured":"Ercan E, Tengiz I, Duman C, Onbasili OA, Baris N (2004) Effect of tirofiban on C-reactive protein in non-ST-elevation myocardial infarction. Am Heart J 147:E1","journal-title":"Am Heart J"},{"key":"183_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.thromres.2006.02.002","volume":"119","author":"EK Iliodromitis","year":"2007","unstructured":"Iliodromitis EK, Andreodou I, Markantonis-Kyroudis S, Mademli K, Kyrzopoulos S, Georgiadou P, Kremastinos DT (2007) The effect of tirofiban on peripheral markers of oxidative stress and endothelial dysfunction in patients with acute coronary syndromes. Thromb Res 119:167\u2013174","journal-title":"Thromb Res"},{"key":"183_CR22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-9560-2-4","volume":"2","author":"E Ercan","year":"2004","unstructured":"Ercan E, Bozdemir H, Tengiz I, Sekuri C, Aliyev E, Akilli A, Akin M (2004) Decreased soluble cell adhesion molecules after tirofiban infusion in patients with unstable angina pectoris. Thromb J 2:4\u201310","journal-title":"Thromb J"},{"key":"183_CR23","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjcard.2004.07.119","volume":"94","author":"A Merino","year":"2004","unstructured":"Merino A, Gaya A, Segura I, Calvo J, Imizcoz C, Berengual A, Alegria E (2004) Platelet aggregation inhibition blocks C-reactive protein and interleukin 6(IL6) elevation after coronary angioplasty: effect of the -174G\/C IL6 gene polymorphism. Am J Cardiol 94:1300\u20131303","journal-title":"Am J Cardiol"},{"key":"183_CR24","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.jacc.2005.12.084","volume":"48","author":"PA Gurbel","year":"2006","unstructured":"Gurbel PA, Bliden KP, Tantry US (2006) Effect of clopidogrel with ant without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study. J Am Coll Cardiol 48:2186\u20132191","journal-title":"J Am Coll Cardiol"},{"key":"183_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14628840410030496","volume":"6","author":"A Finkelstein","year":"2004","unstructured":"Finkelstein A, Izraelov S, Roth A, Ben-Shmuel S, Keren G, Miller H, George J (2004) Eptifibatide does not influence lymphocyte activation and CRP levels in patients undergoing coronary angioplasty. Int J Cardiovasc Intervent 6:107\u2013109","journal-title":"Int J Cardiovasc Intervent"},{"key":"183_CR26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.ATV.18.9.1359","volume":"18","author":"PM Mannucci","year":"1998","unstructured":"Mannucci PM (1998) Von Willebrand factor: a marker of endothelial damage. Arterioscler Thromb Vasc Biol 18:1359\u20131362","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"183_CR27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0021-9150(96)05980-1","volume":"128","author":"AD Blann","year":"1997","unstructured":"Blann AD, Lip GYH (1997) Hypothesis: is soluble P-selectin a new marker of platelet activation. Atherosclerosis 128:135\u2013138","journal-title":"Atherosclerosis"},{"key":"183_CR28","first-page":"49","volume":"46","author":"AA Mazaev","year":"2006","unstructured":"Mazaev AA, Naimushin YA, Mazurov AV, Ruda MI (2006) Glycoprotein IIb-IIIa antagonist eptifibatide in acute coronary syndrome without elevation of ST segment. Kardiologiia 46:49\u201355 (Russian)","journal-title":"Kardiologiia"},{"key":"183_CR29","first-page":"1570","volume":"64","author":"AV Semenov","year":"1999","unstructured":"Semenov AV, Romanov YA, Loktionova SA, Tikhomirov OY, Khachikian MV, Vasil\u2019ev SA, Mazurov AV (1999) Production of soluble P-selectin by platelets and endothelial cells. Biochemistry (Moscow) 64:1570\u20131582","journal-title":"Biochemistry (Moscow)"},{"key":"183_CR30","first-page":"20","volume":"50","author":"EV Yanushevskaya","year":"2005","unstructured":"Yanushevskaya EV, Barkevitch EA, Khaspekova SG, Naimushin YA, Vlasik TN, Likhacheva EA, Pluesch OP, Mazurov AV (2005) Measurement of von Willebrand factor with ELISA based on monoclonal antibodies. Application of the method for diagnosis of von Willebrand disease. Gematol Transfuziol 50:20\u201325 (Russian)","journal-title":"Gematol Transfuziol"},{"key":"183_CR31","first-page":"15","volume":"72","author":"AV Semenov","year":"2000","unstructured":"Semenov AV, Kagan-Ponomarev MYa, Ruda MIa, Komarov AL, Panchenko EP, Chazova IE, Mazurov AV (2000) Soluble P-selectin \u2013 a marker of platelet activation and vessel wall injury. Increase of soluble P-selectin in blood plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension. Ter Arkhiv 72:15\u201320 (Russian)","journal-title":"Ter Arkhiv"},{"key":"183_CR32","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/01.CIR.92.7.1693","volume":"92","author":"H Ikeda","year":"1995","unstructured":"Ikeda H, Takajo Y, Ichiki K, Ueno K, Maki S, Noda T, Suqi K, Imaizumi T (1995) Increased soluble form of P-selectin in patients with unstable angina. Circulation 92:1693\u20131696","journal-title":"Circulation"},{"key":"183_CR33","first-page":"661","volume":"47","author":"KL Streetz","year":"2001","unstructured":"Streetz KL, Wustefed T, Klein C, Manns MP, Trautwein C (2001) Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand) 47:661\u2013673","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"183_CR34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","volume":"104","author":"A Bernardo","year":"2004","unstructured":"Bernardo A, Ball C, Nolasco L, Moake JF, Dong J (2004) Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 104:100\u2013106","journal-title":"Blood"},{"key":"183_CR35","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0002-9149(03)00327-8","volume":"91","author":"A Aggrawal","year":"2003","unstructured":"Aggrawal A, Schneider DJ, Terrien EF, Terrien CM, Sobel BE, Dauerman HL (2003) Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interlukin-1 receptor antagonist after coronary arterial stenting. Am J Cardiol 91:1346\u20131349","journal-title":"Am J Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-007-0183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-007-0183-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-007-0183-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:01:38Z","timestamp":1559386898000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-007-0183-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,28]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1007\/s11239-007-0183-9","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,28]]}}}